Search Results 1291-1300 of 17411 for gluten intolerance

1. Study of Orally Administered AG-120 in Subjects with Advanced Hematologic Malignancies with an IDH1 Mutation - Mayo Clinic

   2012), that is recurrent or refractory, or the subject is intolerant to established therapy known to provide clinical benefit for their condition (i.e. ...

2. Crohn's disease - Doctors and departments - Mayo Clinic

   Learn about symptoms and treatment for this debilitating, but treatable, digestive condition.

3. High blood protein When to see a doctor - Mayo Clinic

   A total protein test may be done. Other, more-specific tests, including serum protein electrophoresis (SPEP), can help find the exact source, such as the liver ...

4. A Study Evaluating KTE-X19 in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r ALL) (ZUMA-3) - Mayo Clinic

   Morphological disease in the bone marrow (≥ 5% blasts); Subjects with Ph+ disease are eligible if they are intolerant to tyrosine kinase inhibitor (TKI) ...

5. Paclitaxel-Coated Pulmonary Balloon For The Treatment Of Benign Central Airway Stenosis - Mayo Clinic

   Allergy to paclitaxel or structurally related compounds 23. Target stenosis is within a transplanted lung or transplant anastomosis, or a tracheal resection ...

6. A Study of Long-Term Outcomes of Cardiac Resynchronization Therapy Recipients with Congestive Heart Failure - Mayo Clinic

   The purpose of this study is to determine the long-term outcome of cardiac resynchronization therapy (CRT) recipients with congestive heart failure and any ...

7. A Study To Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC - Mayo Clinic

   A Study To Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early ...

8. Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL) - Mayo Clinic

   Clinical Trials · Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL) · More about research at ...

9. Portal hypertension - Doctors and departments - Mayo Clinic

   This condition slows or blocks blood flow through the liver. Treatment is key to help prevent and manage serious complications such as bleeding.

10. A Study to Assess the Effectiveness and Safety of Ublituximab in combination with Umbralisib and Venetoclax (U2-V) Compared to Ublituximab and Umbralisib (U2) in Subjects with Chronic Lymphocytic Leukemia (CLL) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...